1207989-22-7
1207989-22-7
Chemical Structure
LGD-6972 sodium
- CAS No.: 1207989-22-7
- Formula:C43H45N2NaO5S
- Molecular Weight:724.88
IUPAC Name: sodium (R)-2-(4-(2-(4'-(tert-butyl)-[1,1'-biphenyl]-4-yl)-3-oxo-3-((2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)amino)propyl)benzamido)ethane-1-sulfonate
InChIKey: UXVQTOIZZKLZCS-DRRLCDGFSA-M
SMILES: O=C(NCCS(=O)(O[Na])=O)C1=CC=C(C[C@H](C2=CC=C(C3=CC=C(C(C)(C)C)C=C3)C=C2)C(NC4=CC=C(C5=C(C)C=C(C)C=C5C)C=C4)=O)C=C1
Biological Activity: LGD-6972 sodium is a selective and orally active glucagon receptor antagonist. LGD-6972 sodium has the potential for type 2 diabetes research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LGD-6972 sodium | LGD-6972 sodium is a selective and orally active glucagon receptor antagonist. LGD-6972 sodium has the potential for type 2 diabetes research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
